Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Siegrist

Showing results (21-30 of 111) with videos related to

Pageof 12
Sort By:
Developments in Biological Standardization|December 17, 1998
Maternal immunity and infant responses to immunization: factors influencing infant responsesC A Siegrist, P H Lambert
Infectious Agents and Disease|January 1, 1996
DNA vaccines: what can we expect?C A Siegrist, P H Lambert
Archives of Disease in Childhood|October 24, 2006
Immunisation of premature infantsJ Bonhoeffer, C-A Siegrist, P T Heath
International Immunology|April 1, 1996
Highly efficient peptide binding and T cell activation by MHC class II molecules of CIITA-transfected cellsE Martinez-Soria, C A Siegrist, B Mach
Viruses|January 25, 2025
Herpesvirus Infections After Chimeric Antigen Receptor T-Cell Therapy and Bispecific Antibodies: A ReviewJoseph Sassine, Emily A Siegrist, Roy F Chemaly
Schweizerische Medizinische Wochenschrift|December 31, 1983
[Anaerobic septicemia following oropharyngeal infections (Lemierre's postanginal septicemia): a forgotten syndrome]B Hirschel, A F Allaz, C A Siegrist
International Immunology|August 1, 1995
The two novel MHC class II transactivators RFX5 and CIITA both control expression of HLA-DM genesI Kern, V Steimle, C A Siegrist, et al.
Revue Medicale Suisse|April 1, 2009
[Allergic reactions and vaccines: distinguishing true and false reactions]J-C Caubet, C-A Siegrist, P A Eigenmann
Revue Medicale Suisse|March 26, 2005
[Recurrent lower respiratory tract infection in children: when and how should they be investigated?]K M Pósfay Barbe, C Barazzone-Argiroffo, C A Siegrist
The Journal of Experimental Medicine|December 1, 1995
A novel antigen-processing-defective phenotype in major histocompatibility complex class II-positive CIITA transfectants is corrected by interferon-gammaC A Siegrist, E Martinez-Soria, I Kern, et al.
Pageof 12

Showing results (21-30 of 111) with videos related to

Sort By:
Pageof 12
Developments in Biological Standardization|December 17, 1998
Maternal immunity and infant responses to immunization: factors influencing infant responsesC A Siegrist, P H Lambert
Infectious Agents and Disease|January 1, 1996
DNA vaccines: what can we expect?C A Siegrist, P H Lambert
Archives of Disease in Childhood|October 24, 2006
Immunisation of premature infantsJ Bonhoeffer, C-A Siegrist, P T Heath
International Immunology|April 1, 1996
Highly efficient peptide binding and T cell activation by MHC class II molecules of CIITA-transfected cellsE Martinez-Soria, C A Siegrist, B Mach
Viruses|January 25, 2025
Herpesvirus Infections After Chimeric Antigen Receptor T-Cell Therapy and Bispecific Antibodies: A ReviewJoseph Sassine, Emily A Siegrist, Roy F Chemaly
Schweizerische Medizinische Wochenschrift|December 31, 1983
[Anaerobic septicemia following oropharyngeal infections (Lemierre's postanginal septicemia): a forgotten syndrome]B Hirschel, A F Allaz, C A Siegrist
International Immunology|August 1, 1995
The two novel MHC class II transactivators RFX5 and CIITA both control expression of HLA-DM genesI Kern, V Steimle, C A Siegrist, et al.
Revue Medicale Suisse|April 1, 2009
[Allergic reactions and vaccines: distinguishing true and false reactions]J-C Caubet, C-A Siegrist, P A Eigenmann
Revue Medicale Suisse|March 26, 2005
[Recurrent lower respiratory tract infection in children: when and how should they be investigated?]K M Pósfay Barbe, C Barazzone-Argiroffo, C A Siegrist
The Journal of Experimental Medicine|December 1, 1995
A novel antigen-processing-defective phenotype in major histocompatibility complex class II-positive CIITA transfectants is corrected by interferon-gammaC A Siegrist, E Martinez-Soria, I Kern, et al.
Pageof 12